(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -92.14%71.12K | -93.32%102.12K | 210.42%306.96K | 542.23%453.47K | 542.23%453.47K | 355.94%904.97K | 91.62%1.53M | -83.89%98.89K | -83.23%70.61K | -83.23%70.61K |
-Cash and cash equivalents | -92.14%71.12K | -93.32%102.12K | 210.42%306.96K | 542.23%453.47K | 542.23%453.47K | 355.94%904.97K | 91.62%1.53M | -83.89%98.89K | -83.23%70.61K | -83.23%70.61K |
-Other receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --38.22K | --38.22K |
Total current assets | -89.90%100.14K | -89.70%164.62K | 82.12%359.48K | 93.71%504.61K | 93.71%504.61K | 115.20%991.81K | 26.67%1.6M | -76.89%197.39K | -54.14%260.5K | -54.14%260.5K |
Non current assets | ||||||||||
-Accumulated depreciation | -20.16%-142.49K | -17.84%-130.02K | -22.13%-122.16K | -39.65%-127.3K | -39.65%-127.3K | -12.06%-118.59K | -10.25%-110.33K | -1.47%-100.03K | ---91.15K | ---91.15K |
Regulatory assets | -63.33%24.75K | 5.67%57.49K | 4.54%43.73K | -44.77%37.85K | -44.77%37.85K | 13.27%67.5K | -21.75%54.41K | 7.51%41.83K | 95.40%68.54K | 95.40%68.54K |
Total assets | -63.33%24.75K | 5.67%57.49K | 4.54%43.73K | -44.77%37.85K | -44.77%37.85K | 13.27%67.5K | -21.75%54.41K | 7.51%41.83K | 95.40%68.54K | 95.40%68.54K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20.41K | ---- | ---- |
-Current debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20.41K | ---- | ---- |
-accounts payable | 5.75%521.9K | 62.18%782.44K | -23.72%589.09K | 31.93%561.15K | 31.93%561.15K | 33.57%493.54K | 96.48%482.44K | 78.82%772.28K | 458.32%425.32K | 458.32%425.32K |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Other payable | 1.36%6.93K | -0.81%6.83K | 0.20%6.89K | 5.74%6.8K | 5.74%6.8K | 2.43%6.84K | 1.94%6.89K | 1.04%6.88K | -6.01%6.43K | -6.01%6.43K |
Current accrued expenses | 17.05%104.09K | 8.43%96.43K | -31.66%88.93K | -68.98%88.93K | -68.98%88.93K | 24.04%88.93K | -53.07%88.93K | 82.66%130.13K | 177.99%286.67K | 177.99%286.67K |
Current liabilities | 36.34%794.15K | 52.67%878.87K | -26.71%679.19K | -13.14%651.63K | -13.14%651.63K | 32.02%582.47K | 32.32%575.65K | 84.19%926.69K | 318.40%750.2K | 318.40%750.2K |
Non current liabilities | ||||||||||
Non current accrued expenses | 77.94%588.48K | 77.29%600.96K | 74.31%608.82K | 338.45%617.99K | 338.45%617.99K | 510.45%330.72K | 497.88%338.97K | 579.07%349.28K | 152.86%140.95K | 152.86%140.95K |
Total non current liabilities | 36.34%794.15K | 52.67%878.87K | -26.71%679.19K | -13.14%651.63K | -13.14%651.63K | 32.02%582.47K | 32.32%575.65K | 84.19%926.69K | 318.40%750.2K | 318.40%750.2K |
Shareholders'equity | ||||||||||
Share capital | 5.68%10.85M | 4.16%10.64M | 37.42%10.64M | 42.41%10.53M | 42.41%10.53M | 36.65%10.27M | 35.98%10.22M | 37.95%7.74M | 31.73%7.39M | 31.73%7.39M |
-common stock | 5.68%10.85M | 4.16%10.64M | 37.42%10.64M | 42.41%10.53M | 42.41%10.53M | 36.65%10.27M | 35.98%10.22M | 37.95%7.74M | 31.73%7.39M | 31.73%7.39M |
Additional paid-in capital | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M | 0.00%6.18M |
Gains losses not affecting retained earnings | 20.46%2.47M | 32.35%2.46M | 100.36%2.36M | 109.62%2.28M | 109.62%2.28M | 90.11%2.05M | 73.96%1.86M | 18.56%1.18M | 15.24%1.09M | 15.24%1.09M |
Total equity | -45.15%756.51K | -58.25%832.49K | 71.59%1.04M | 161.54%1.19M | 161.54%1.19M | 141.83%1.38M | 45.12%1.99M | -37.24%603.63K | -33.17%454.69K | -33.17%454.69K |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.